ESMO 2023 Insights: "Multiparametric Prognostic Score in HR+/HER2- EBC - Impact of Recurrence Score, Clinical-Pathological Factors, Gene Mutations and Histology"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

ESMO 2023 Insights: "Multiparametric Prognostic Score in HR+/HER2- EBC - Impact of Recurrence Score, Clinical-Pathological Factors, Gene Mutations and Histology"

By Insights from 2023 ESMO Annual Meeting FEATURING Oleg Gluz

80 views

October 31, 2023

0 Comments

London Breast Meeting 2024

Wed, Sep 4, 2024

11:31

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Top 5 Abstracts Summary: "SONIA, NATALEE, PHERGain, …

Feat. P. Tarantino

12:35

Insights from 2023 SABCS

SABCS 2023 Summary: "What Is the Appropriate 1L Therapy for ER+…

Feat. S. Tolaney, H. Rugo

28:36

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "eBC Expert Panel Discussion on Key Trials …

Feat. H. Rugo, K. Jhaveri

03:40

Integrity Continuing Education

SABCS 2023 Insights: "CAPItello-291 Trial - Capivasertib & …

Feat. A. Bardia

14:16

Dana-Farber Cancer Institute

Year in Review: Breast Cancer

Feat. P. Tarantino

17:39

Yale School of Medicine

2023 Menopause Update

Feat. M. Minkin

17:20

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Top 5 Breast Cancer Studies Including KEYNO…

Feat. P. Tarantino

09:19

Insights from 2023 SABCS

SABCS 2023 Insights: "Biology or Stage? Tailoring Treatment for…

Feat. K. Kalinsky

57:44

Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl

04:28

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ASCENT-05/OptimICE-RD (AFT-65): Adjuvant …

Feat. S. Tolaney

05:43

Total Health

Neoadjuvant Chemo for HR+ BC: Year in Review

Feat. C. Ma

07:23

Total Health

Advanced Stage HR+ BC: Fine-Tuning Sequential Endocrine and Targeted…

Feat. R. O'Regan

10:27

Insights from 2023 SABCS

SABCS 2023 Summary: "What Is the Role for CDK 4/6i in the Adjuv…

Feat. S. Tolaney, H. Rugo

49:07

SABCS 2022 Conference Coverage

SABCS 2022 Expert Panel Discussion: Practice-Changing Updates

Feat. J. O'Shaughnessy, S. Tolaney, S. Hurvitz, H. Rugo

22:34

Dana-Farber Cancer Institute

What's New in Breast Cancer?

Feat. S. Tolaney

50:59

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Panel Discussion: "Early Stage Breast Cancer"

Feat. S. Tolaney, H. Rugo

17:35

Insights from 2023 SABCS

SABCS 2023 Summary: "Top 5 Studies Including KATHERINE & HE…

Feat. P. Tarantino

27:04

Fengting Yan

Cancer Screening Molecular Tools

28:23

Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

Anthracyclines for Early Stage Breast Cancer - Do They Still Have a …

Feat. V. Borges

07:18

V.K. Gadi

Login

Login

Join VuMedi

ESMO 2023 Insights: "Multiparametric Prognostic Score in HR+/HER2- EBC - Impact of Recurrence Score, Clinical-Pathological Factors, Gene Mutations and Histology"

Related Content